 |
|
The Challenge of Stroke Prevention
Daniel F. Hanley, MD
JAMA. 2004;291:621-622.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Stroke prevention represents a critical health challenge. The demographics of aging and the association of stroke with aging bring together factors that compel a concerted effort to limit the individual and societal risks of a worldwide epidemic of stroke.1 As a disease, stroke functions on 2 biological frontiers: aging and brain vascular function. Society has recognized the epidemic of atherosclerotic vascular disease for the last 4 decades and has begun to deal with the cardiac consequences of atherosclerosis. These efforts are apparent in the public domain and in the physician's office. Multiple acute interventions and prevention programs are available to limit acute disease and delay or reverse coronary artery narrowing and help prevent progression to subsequent myocardial infarctions.
Unfortunately, such is not the case with stroke. Embolic stroke and carotid stenosis represent treatable subsets of stroke etiologies. Aspirin can provide partial prevention, but the majority of . . . [Full Text of this Article]
Author Affiliation: Division of Brain Injury Outcomes, Johns Hopkins Medical Institutions, Baltimore, Md.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
From the Library
Br J Ophthalmol 2004;88:726-726.
FULL TEXT
Reducing homocysteine levels does not prevent stroke recurrence
Gottlieb
BMJ 2004;328:307.
FULL TEXT
|
